Skip to main content
Clinical Trials/NCT02203097
NCT02203097CompletedPhase 4

The Effect of Different End-tidal Carbon-dioxide Levels on Cerebral CO2 Vasoreactivity and the Stiffness of Systemic Arteries During Propofol Anesthesia

University of Debrecen1 site in 1 country25 target enrollmentStarted: January 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
25
Locations
1
Primary Endpoint
Blood flow velocity in the middle cerebral artery

Study Overview

Brief Summary

Purpose:

The purpose of this study is to examine the effect of different carbon-dioxide concentrations on cerebral CO2 sensitivity and the resistance and stiffness of systemic arteries during anesthesia with target-controlled infusion anesthesia using intravenous propofol. Propofol is a widely and commonly used intravenous anaesthetic, that is mainly used for the induction of general anesthesia and the maintenance of total intravenous anaesthesia (TIVA).

Changes in the velocity of cerebral blood flow and arterial stiffness due to the different exhaled carbon-dioxide concentrations will allow us to conclude how propofol affects these parameters during the course of the narcosis.

Instruments:

An ultrasound device called transcranial doppler (TCD) is used to measure the velocity of blood flow within a main artery located inside the skull.

A tonometry device named SphygmoCor is used to assess the pressure wave proceeding in the radial artery, from which the stiffness of the systemic vessels can be concluded.

Measurements:

  • Examinations with the ultrasound and tonometry devices are carried out once before the operation, three times during the intervention, with different exhaled CO2 values and once after the operation is completed.

Hypothesis:

  • Propofol alters cerebral carbon-dioxide sensitivity and the stiffness of systemic arteries during TCI anaesthesia.

Detailed Description

Study protocol:

  • The study is conducted in four stages: in the first stage, measurements are performed preoperatively in awake patients. Patients are placed in supine position and mean arterial blood pressure (MAP), heart rate, oxygen saturation are measured. The transcranial doppler (TCD) probe is fixed in place by applying a headband to maintain a constant angle of insonation. Mean blood flow velocity (MBFV) and pulsatility index (PI) in the middle cerebral artery (MCA) are obtained. MCA is insonated through the right temporal window by using pulsed 2 megahertz TCD ultrasound probe. Identification of the MCA is confirmed by using standard criteria, at a depth of 45-55 mm. Cerebral CO2 vasoreactivity is calculated as the percentage change in MBFV or PI for mmHg change in end-tidal CO2 (ETCO2).

SphygmoCor is placed on the left radial artery to obtain data about the central aortic blood pressure, augmentation pressure (AP) and augmentation index normalised to a 75 beat per minute heart rate (Alx75). From the derived aortic pulse, calculations can be made, using the area under the systolic and diastolic part of the curve, to determine the heart's ratio of oxygen supply and demand, it is called the subendocardial viability ratio (SEVR).

As part of the premedication each patient receives 100 mg diclofenac per os 30 minutes and 500 ml Lactated-Ringer infusion 60 minutes prior to the operation.

Anesthesia is induced and maintained with target-controlled infusion anesthesia (TCI) using intravenous propofol at 4 mcg/ml constant plasma concentration. Analgesia is provided by using 2 ug/kg sufentanyl bolus dose at the time of induction. Afterwards 0.6 mg/kg rocuronium is given for muscle paralysis and subsequently patients were intubated with a suitable intratracheal tube. After induction of anaesthesia, the patients are placed on a mechanical ventilation system, using a volume-controlled setting with an air and oxygen mixture set to 0.4 fraction of inspired oxygen (FiO2) , the fresh gas flow rate to 2 l/min. .

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Above the age 18
  • American Society of Anesthesiologists (ASA) physical classification I. or II.
  • Patients undergoing elective varicotomy, inguinal hernioplasty or breast surgery in general anesthesia

Exclusion Criteria

  • Patients with cerebral, cardiac or systemic vascular disorders (hypertension, diabetes)
  • Patients receiving medication that affects the blood vessels (antihypertensive, antidiabetic, antiarrhythmic medications)

Arms & Interventions

Propofol

Experimental

Propofol is administered to all patients via target-controlled infusion (TCI) to reach 4 mcg/ml constant plasma concentration according to the Schneider model during the course of the narcosis.

Intervention: Partial pressure of CO2 at the end of an exhaled breath (Procedure)

Propofol

Experimental

Propofol is administered to all patients via target-controlled infusion (TCI) to reach 4 mcg/ml constant plasma concentration according to the Schneider model during the course of the narcosis.

Intervention: Propofol (Drug)

Outcomes

Primary Outcomes

Blood flow velocity in the middle cerebral artery

Time Frame: Changes from baseline in blood flow velocity at the 15th, 20th and 25th minutes of the operation

Systolic, diastolic and mean blood flow velocities are measured with transcranial doppler device.

Secondary Outcomes

  • Changes in the central systolic and diastolic blood pressure(Changes from baseline in central blood pressure at the 15th, 20th and 25th minutes of the operation)
  • Arterial wall stiffness of the radial artery(Changes from baseline in arterial stiffness at the 15th, 20th and 25th minutes of the operation)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tamas Vegh, MD

assistant lecturer anesthesiologist and intensive care specialist

University of Debrecen

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Phase 2
A comparative study of targeted end-tidal carbon dioxide (EtCO2) versus standard EtCO2 management to guide resuscitation in emergency department cardiac arrest: a randomized controlled trialPatients experiencing cardiac arrest in the emergency department (EDCA). This includes patients who experienced their first cardiac arrest outside the hospital (OHCA) and then had a recurrent arrest in the emergency department, as well as patients who experienced their first cardiac arrest while already in the emergency department (IHCA).end-tidal carbon dioxide, targeted EtCO2, emergency department cardiac arrest, ROSC, high-quality CPR, improving mortality, reducing mortality
TCTR20240619001Thammasat University300
Completed
Not Applicable
Correlation Between Changes in End-Tidal Carbon Dioxide and Stroke Volume Variation Detected by Electrical Cardiometry as A Predictor of Fluid Volume Responsiveness in Hemodynamically Unstable Patients in the Intensive CareEnd Tidal Carbon DioxideCardiometryFluid ResponsivenessShock
NCT03932617Tanta University60
Not yet recruiting
Not Applicable
Comarison of two ventilatory modes on blood and end tidal carbon dioxide in patients undergoing robotic prostate surgery
CTRI/2020/08/027354Amrita Institute of Medical Sciences
Completed
Not Applicable
Comparison of end tidal carbon dioxide level along the time of surgery between pressure support ventilation versus spontaneous ventilation in general anesthesia under laryngeal mask airway in breast surgeryPatients ASA 1&#452 who undergo breast surgery unger general anesthesia with laryngeal mask airway
TCTR20190806001o38
Not yet recruiting
Phase 2
To monitor the changes in optic nerve diameter with level of expired Carbon dioxide in children under sedation.
CTRI/2024/02/062446Dr Shravankumar V